Global Measles and Rubella Vaccine market growth is projected to reach  US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Measles and Rubella Vaccine Market Trends and Analysis 2025-31

The global Measles and Rubella Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Measles and Rubella Vaccine is a live virus vaccine used to vaccinate against measles and rubella. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Measles and Rubella Vaccine Industry Forecast looks at past sales and reviews total world Measles and Rubella Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Measles and Rubella Vaccine sales for 2025 through 2031. With Measles and Rubella Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Measles and Rubella Vaccine industry. This Insight Report provides a comprehensive analysis of the global Measles and Rubella Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Measles and Rubella Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Measles and Rubella Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Measles and Rubella Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Measles and Rubella Vaccine. This report presents a comprehensive overview, market shares, and growth opportunities of Measles and Rubella Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Inactivated Vaccines &nbsp;&nbsp;&nbsp; Live Attenuated Vaccines Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Serum Institute of India Pvt. Ltd. &nbsp;&nbsp;&nbsp; Incepta Vaccine Ltd. &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Sanofi Key Questions Addressed in this Report What is the 10-year outlook for the global Measles and Rubella Vaccine market? What factors are driving Measles and Rubella Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Measles and Rubella Vaccine market opportunities vary by end market size? How does Measles and Rubella Vaccine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Measles and Rubella Vaccine Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Measles and Rubella Vaccine by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Measles and Rubella Vaccine by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Measles and Rubella Vaccine Segment by Type &nbsp;2.2.1 Inactivated Vaccines &nbsp;2.2.2 Live Attenuated Vaccines &nbsp;2.3 Measles and Rubella Vaccine Sales by Type &nbsp;2.3.1 Global Measles and Rubella Vaccine Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Measles and Rubella Vaccine Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Measles and Rubella Vaccine Sale Price by Type (2020-2025) &nbsp;2.4 Measles and Rubella Vaccine Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.5 Measles and Rubella Vaccine Sales by Application &nbsp;2.5.1 Global Measles and Rubella Vaccine Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Measles and Rubella Vaccine Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Measles and Rubella Vaccine Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Measles and Rubella Vaccine Breakdown Data by Company &nbsp;3.1.1 Global Measles and Rubella Vaccine Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Measles and Rubella Vaccine Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Measles and Rubella Vaccine Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Measles and Rubella Vaccine Revenue by Company (2020-2025) &nbsp;3.2.2 Global Measles and Rubella Vaccine Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Measles and Rubella Vaccine Sale Price by Company &nbsp;3.4 Key Manufacturers Measles and Rubella Vaccine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Measles and Rubella Vaccine Product Location Distribution &nbsp;3.4.2 Players Measles and Rubella Vaccine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Measles and Rubella Vaccine by Geographic Region &nbsp;4.1 World Historic Measles and Rubella Vaccine Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Measles and Rubella Vaccine Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Measles and Rubella Vaccine Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Measles and Rubella Vaccine Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Measles and Rubella Vaccine Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Measles and Rubella Vaccine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Measles and Rubella Vaccine Sales Growth &nbsp;4.4 APAC Measles and Rubella Vaccine Sales Growth &nbsp;4.5 Europe Measles and Rubella Vaccine Sales Growth &nbsp;4.6 Middle East & Africa Measles and Rubella Vaccine Sales Growth 5 Americas &nbsp;5.1 Americas Measles and Rubella Vaccine Sales by Country &nbsp;5.1.1 Americas Measles and Rubella Vaccine Sales by Country (2020-2025) &nbsp;5.1.2 Americas Measles and Rubella Vaccine Revenue by Country (2020-2025) &nbsp;5.2 Americas Measles and Rubella Vaccine Sales by Type (2020-2025) &nbsp;5.3 Americas Measles and Rubella Vaccine Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Measles and Rubella Vaccine Sales by Region &nbsp;6.1.1 APAC Measles and Rubella Vaccine Sales by Region (2020-2025) &nbsp;6.1.2 APAC Measles and Rubella Vaccine Revenue by Region (2020-2025) &nbsp;6.2 APAC Measles and Rubella Vaccine Sales by Type (2020-2025) &nbsp;6.3 APAC Measles and Rubella Vaccine Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Measles and Rubella Vaccine by Country &nbsp;7.1.1 Europe Measles and Rubella Vaccine Sales by Country (2020-2025) &nbsp;7.1.2 Europe Measles and Rubella Vaccine Revenue by Country (2020-2025) &nbsp;7.2 Europe Measles and Rubella Vaccine Sales by Type (2020-2025) &nbsp;7.3 Europe Measles and Rubella Vaccine Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Measles and Rubella Vaccine by Country &nbsp;8.1.1 Middle East & Africa Measles and Rubella Vaccine Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Measles and Rubella Vaccine Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Measles and Rubella Vaccine Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Measles and Rubella Vaccine Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Measles and Rubella Vaccine &nbsp;10.3 Manufacturing Process Analysis of Measles and Rubella Vaccine &nbsp;10.4 Industry Chain Structure of Measles and Rubella Vaccine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Measles and Rubella Vaccine Distributors &nbsp;11.3 Measles and Rubella Vaccine Customer 12 World Forecast Review for Measles and Rubella Vaccine by Geographic Region &nbsp;12.1 Global Measles and Rubella Vaccine Market Size Forecast by Region &nbsp;12.1.1 Global Measles and Rubella Vaccine Forecast by Region (2026-2031) &nbsp;12.1.2 Global Measles and Rubella Vaccine Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Measles and Rubella Vaccine Forecast by Type (2026-2031) &nbsp;12.7 Global Measles and Rubella Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Merck &nbsp;13.1.1 Merck Company Information &nbsp;13.1.2 Merck Measles and Rubella Vaccine Product Portfolios and Specifications &nbsp;13.1.3 Merck Measles and Rubella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Merck Main Business Overview &nbsp;13.1.5 Merck Latest Developments &nbsp;13.2 Serum Institute of India Pvt. Ltd. &nbsp;13.2.1 Serum Institute of India Pvt. Ltd. Company Information &nbsp;13.2.2 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Product Portfolios and Specifications &nbsp;13.2.3 Serum Institute of India Pvt. Ltd. Measles and Rubella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Serum Institute of India Pvt. Ltd. Main Business Overview &nbsp;13.2.5 Serum Institute of India Pvt. Ltd. Latest Developments &nbsp;13.3 Incepta Vaccine Ltd. &nbsp;13.3.1 Incepta Vaccine Ltd. Company Information &nbsp;13.3.2 Incepta Vaccine Ltd. Measles and Rubella Vaccine Product Portfolios and Specifications &nbsp;13.3.3 Incepta Vaccine Ltd. Measles and Rubella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Incepta Vaccine Ltd. Main Business Overview &nbsp;13.3.5 Incepta Vaccine Ltd. Latest Developments &nbsp;13.4 GSK &nbsp;13.4.1 GSK Company Information &nbsp;13.4.2 GSK Measles and Rubella Vaccine Product Portfolios and Specifications &nbsp;13.4.3 GSK Measles and Rubella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 GSK Main Business Overview &nbsp;13.4.5 GSK Latest Developments &nbsp;13.5 Sanofi &nbsp;13.5.1 Sanofi Company Information &nbsp;13.5.2 Sanofi Measles and Rubella Vaccine Product Portfolios and Specifications &nbsp;13.5.3 Sanofi Measles and Rubella Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Sanofi Main Business Overview &nbsp;13.5.5 Sanofi Latest Developments 14 Research Findings and Conclusion

Report	Global Measles and Rubella Vaccine Market Growth 2025-2031
Selected License	Multi ID: LPI14078

Buyer Information

Order Summary